ccinfoadmin
Galactosylation of serum immunoglobulin G in myasthenia gravis with different autoantibodies
Volume 83, Issue 5, September 2023, Page 348-355.
SUMO specific peptidase 1 decreases after induction treatment, and its reduction predicts lower disease risk, better treatment response, longer survival of acute myeloid leukemia
Volume 83, Issue 5, September 2023, Page 283-289.
Normalized TSH strategy can improve the initial assessment of thyroid nodules
Volume 83, Issue 5, September 2023, Page 318-322.
Cardiohepatic syndrome and its prognostic predictive ability in patients with pulmonary arterial hypertension
Volume 83, Issue 5, September 2023, Page 290-298.
Validation of an indirect ELISA assay for assessment of autoantibodies against full-length TRIM21 and its individual domains
Volume 83, Issue 5, September 2023, Page 309-317.
Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia
Volume 83, Issue 5, September 2023, Page 340-347.
Rest reduces venous lactate levels significantly in patients in outpatient clinic
Volume 83, Issue 5, September 2023, Page 336-339.
Prognostic performance of neutrophil CD64 expression in patients with complicated intra-abdominal infections – a prospective study
Volume 83, Issue 5, September 2023, Page 323-329.
Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods
Volume 83, Issue 5, September 2023, Page 330-335.